Invox Pharma Limited
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 25, 2027The maintenance fee for Compounds, compositions, and methods for the treatment of disease (US 11,707,531) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Mar 5, 2027The maintenance fee for Compounds,compositions, and Methods for the Treatment of Disease (US 11,744,845) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,033,569 | Compounds,compositions, and Methods for the Treatment of Disease In force · High confidence | In force | High confidence | |
| US 11,744,845 | Compounds,compositions, and Methods for the Treatment of Disease In force · High confidence | In force | High confidence | |
| US 11,214,618 | LAG-3 binding members In force · From the USPTO record | In force | From the USPTO record | |
| US 11,214,620 | Binding molecules binding PD-L1 and LAG-3 In force · From the USPTO record | In force | From the USPTO record | |
| US 12,390,668 | Compounds, compositions, and methods for the treatment of disease In force · From the USPTO record | In force | From the USPTO record | |
| US 12,187,761 | Compounds, compositions, and methods for the treatment of disease In force · From the USPTO record | In force | From the USPTO record | |
| US 12,187,798 | LAG-3 binding members In force · From the USPTO record | In force | From the USPTO record | |
| US 11,584,774 | Compounds, compositions, and methods for the treatment of disease In force · From the USPTO record | In force | From the USPTO record | |
| US 11,638,716 | Compounds, Compositions, and Methods for the Treatment of Disease In force · High confidence | In force | High confidence | |
| US 11,707,531 | Compounds, compositions, and methods for the treatment of disease In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 20: 2 patents in force now held by others · 1 lapsed for an unpaid fee · 1 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 4 no status recorded